Disufenton sodium

Disufenton sodium
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 2016-08-22 00:00:00
Sponsor Oblato, Inc.;116 Village Boulevard;Princeton, New Jersey, 08540
Related Access Program
Center Trials & Treatment – Glioblastoma by Gene Expression Profile Center Trials & Treatment – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Celldex Therapeutics – Recurrent GBM